Epclusa 200mg/50mg granules sachets (Gilead Sciences Ltd)
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Epclusa 200mg/50mg granules sachets | Start Date 09-01-2023 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
Codes
Code | Start Date | End Date |
---|---|---|
41395911000001105 | 09-01-2023 |
Parent Products
-
VTMSofosbuvir + Velpatasvir
-
VMPSofosbuvir 200mg / Velpatasvir 50mg granules sa...
-
AMP(Current) Epclusa 200mg/50mg granules sa...
-
-
Actual Medicinal Product Pack (AMPP) Information
Pack Size | Indicative Price | Discontinued |
---|---|---|
28 sachet | 1299333 |